Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with an IPO date between August 28, 1995 and August 28, 2025, returning 10,558.7%.

ASSET	% RETURN
Regencell Bioscience (RGC)	10,558.68%
CannBioRx Life Sciences (ATNFW)	4,287.76%
WW International, Inc Common Stock (WW)	2,386.26%
DeFi Development (DFDV)	2,167.8%
HCM II Acquisition (HONDW)	2,124.14%
Oncology Institute (TOIIW)	1,447.62%
BT Brands Inc Warrant (BTBDW)	1,340.53%
Zepp Health (ZEPP)	1,337.31%
Diginex Limited Ordinary Shares (DGNX)	1,272.07%
CEA Industries (BNCWW)	1,242.28%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	1,233.33%
FiEE (FIEE)	1,207.34%
CEA Industries (VAPEW)	1,108.05%
Asset Entities Inc Class B Common Stock (ASST)	1,082%
USA Rare Earth (USARW)	1,054%
Oncology Institute (TOI)	1,030.72%
Abivax SA American Depositary Shares (ABVX)	997.1%
Webull Corporation Warrants (BULLW)	901.72%
Global Interactive Technologies (GITS)	858.51%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	792.4%
Protagenic Therapeutics (PTIXW)	789.23%
TMC the metals company Inc Warrants (TMCWW)	772.64%
Above Food Ingredients Inc Warrants (ABVEW)	744.09%
ThredUp (TDUP)	697.92%
SRM Entertainment, Inc Common Stock (SRM)	693.52%